Inserm Transfert, founded in 2000, is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding. It works under a Public Service Concession Agreement (CSP).
patent families*
number of contracts and licenses*
* For the year 2024
millions of euros invested in Proof of concept
projects detected*
Serving research
The company supports Inserm research units and researchers in the process undertaken to create value from their work. Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value.
25 ans d'Inserm Transfert : un moment inoubliable pour célébrer l'innovation !
De la recherche académique à l’innovation médicale : retour sur
À l’occasion de la Journée de la Créativité et de l’Innovation, nous donnons la parole aux acteurs de ce projet, une innovation de rupture pour faire évoluer le diagnostic non invasif de l’insuffisance cardiaque : Thierry Sarda, CEO ...
21/04/2026You are